Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monomeric chemically modified allergens: immunologic and physicochemical characterization

G Mistrello1, O Brenna, D Roncarolo

  • 1Department of Research, Laboratorio Famacautico Lofarma, Milan, Italy.

Allergy
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents.

ESMO open·2024
Same author

Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer.

Breast (Edinburgh, Scotland)·2022
Same author

Sensitization to Gibberellin-Regulated Protein (Peamaclein) Among Italian Cypress Pollen-Sensitized Patients.

Journal of investigational allergology & clinical immunology·2020
Same author

Allergen Immunotherapy in the Era of SARS-CoV-2.

Journal of investigational allergology & clinical immunology·2020
Same author

Evaluation of two commercial peach extracts for skin prick testing in the diagnosis of hypersensitivity to lipid transfer protein. A multicenter study.

European annals of allergy and clinical immunology·2020
Same author

The role of allergoids in allergen immunotherapy: from injective to sublingual route.

European annals of allergy and clinical immunology·2020

Chemically modified (carbamylated) allergens show reduced allergenic potency while retaining the ability to induce cross-reactive IgG antibodies. This modification preserves the allergen

Area of Science:

  • Immunology
  • Allergy Research
  • Biochemistry

Background:

  • Allergenic extracts and specific allergens are crucial in allergy research and diagnostics.
  • Chemical modification of allergens is explored to reduce their allergenic potency for potential therapeutic applications.

Purpose of the Study:

  • To investigate the effects of chemical modification using potassium cyanate (KCNO) on the allergenic potency and immunogenicity of various allergens.
  • To evaluate the potential clinical applications of these modified allergens.

Main Methods:

  • Allergens (Der p, grass, Parietaria extracts, Par j I, ovalbumin) were chemically modified with KCNO, converting lysine epsilon-amino groups to ureido groups (carbamylation).
  • Allergenic potency was assessed using in vitro (RAST inhibition) and in vivo (passive cutaneous anaphylaxis) assays.

Related Experiment Videos

  • Immunogenicity was evaluated by immunizing rabbits and analyzing IgG antibody cross-reactivity with native allergens via immunoblotting.
  • Structural integrity was confirmed using SDS-PAGE analysis to demonstrate preservation of native monomeric dimensions.

    • Main Results:

    • KCNO-modified (carbamylated) allergens exhibited significantly reduced allergenic potency in both in vitro and in vivo tests.
    • Despite reduced potency, carbamylated allergens successfully induced IgG antibodies in rabbits that cross-reacted with native allergens.
    • SDS-PAGE analysis confirmed that carbamylation preserved the native monomeric size of the allergens, unlike some other chemical modifications.

    Conclusions:

    • Carbamylation is an effective method for reducing the allergenic potency of proteinaceous allergens.
    • Carbamylated allergens retain immunogenicity, inducing cross-reactive IgG antibodies, suggesting potential for immunotherapy.
    • The preservation of native monomeric dimensions is a key feature of carbamylated allergens, potentially advantageous for clinical applications.